GENEVA, July 2 -- CURSUS BIO INC. filed a patent application (KR2024/097002) for “NUCLEIC ACID CONSTRUCT FOR INHIBITING FABP5, AND COMPOSITION FOR TREATING OBESITY OR OBESITY-INDUCED METABOLIC DISEASES”. With publication no. WO/2026/134403, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....